Measuring and Valuing Outcomes
We have established an excellent reputation for leading innovative, ideas-driven, and theoretically sound research on the measurement and valuation of outcomes. Health care systems should put patient-relevant outcomes at the heart of decisions about funding and providing health and social care.
Productivity Costs: Principles and Practice in Economic Evaluation
11 January 2000
The Secretary of State for Health has recently described health care as a form of ‘social investment’ which is ‘of instrumental importance in improving national economic…
Public Involvement in Priority Setting
1 September 1999
International and UK experience illustrates the difficulty of involving the publica in health caare priority setting in ways that enable politicians, managers and doctors to incorporate…
Doctors, Economics and Clinical Practice Guidelines: Can they be brought together?
1 January 1999
The topic I have been asked to address, ‘Doctors, Economics and Clinical Practice Guidelines: Can they be Brought Together’, is both difficult and controversial. It is…
From Efficacy to Cost-Effectiveness
1 May 1998
The advantage of such trials is high internal validity, i.e. relative freedom from dangers of confounding bias, as compared to other forms of research. Economic evaluations,…
Trends in Economic Evaluation
1 April 1998
The aim of this paper is to consider recent trends in the volume and characteristics of economic evaluation literature by interrogating the Health Economic Evaluations Database…
Guidelines for the Economic Evaluation of Pharmaceuticals: Can the UK learn from Australia and Canada?
1 May 1997
Getting value for money from the use of pharmaceuticals is crucial for the NHS. This publication explores the role for guidelines in generating good quality value for money information examining the experience of Australia, Canada and the UK – the first three health care systems to introduce national guidelines for economic assessments.
The Pros and Cons of Modelling in Economic Evaluation
1 May 1997
The participants were: Professor Bernard Bloom. University of Pennsylvania, USA Professor Martin Buxton. Director of the Health Economics Research Group, University of Brunel, UK Professor Michael…
Uses of Models in Economic Evaluations of Medicines and Other Health Technologies
1 October 1996
The use of models in economic studies evaluating medicines and other health technologies has become a controversial issue. This is because study results now matter –…
Using Consumer Preferences in Health Care Decision Making: The Application of Conjoint Analysis
1 April 1996
The idea that clients or users of public services might legitimately have opinions about how they should be delivered is a relatively new one in the…